Medpace
(NASDAQ) MEDP
Medpace Financials at a Glance
Market Cap
$11.24B
Revenue (TTM)
$2.68B
Net Income (TTM)
$460.40M
EPS (TTM)
$15.90
P/E Ratio
24.74
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$411.33
Volume
41,812
Open
$393.99
Price
$411.33
Volume
41,812
Open
$393.99
Previous Close
$411.33
Daily Range
$392.27 - $415.83
52-Week Range
$284.10 - $628.92
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$411.33
Volume
41,812
Open
$393.99
Previous Close
$411.33
Daily Range
$392.27 - $415.83
52-Week Range
$284.10 - $628.92
MEDP News
Why Medpace Popped 13% This Week
Why Medpace Stock Soared Today
MEDP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Medpace
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
6,200
CEO
August James Troendle, MD
Website
www.medpace.comHeadquarters
Cincinnati, OH 45227, US
MEDP Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
21%
Net Income Margin
17%
Return on Equity
77%
Return on Capital
72%
Return on Assets
22%
Earnings Yield
4.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.24B
Shares Outstanding
28.56M
Volume
41.81K
Short Interest
0.00%
Avg. Volume
395.46K
Financials (TTM)
Gross Profit
$760.62M
Operating Income
$534.93M
EBITDA
$570.50M
Operating Cash Flow
$713.22M
Capital Expenditure
$31.36M
Free Cash Flow
$681.87M
Cash & ST Invst.
$497.05M
Total Debt
$250.50M
Medpace Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$706.60M
+26.5%
Gross Profit
$196.33M
+10.1%
Gross Margin
27.78%
N/A
Market Cap
$11.24B
N/A
Market Cap/Employee
$1.90M
N/A
Employees
5,900
N/A
Net Income
$123.87M
+8.1%
EBITDA
$148.41M
+23.2%
Quarterly Fundamentals
Net Cash
$530.42M
+68.5%
Accounts Receivable
$394.58M
+32.3%
Inventory
$0.00
N/A
Long Term Debt
$244.51M
+93.0%
Short Term Debt
$244.51M
N/A
Return on Assets
21.62%
N/A
Return on Invested Capital
71.75%
N/A
Free Cash Flow
$151.79M
+31.0%
Operating Cash Flow
$151.79M
+20.6%